Steven Ross Johnson November
13, 2019
The Centers for Disease Control and
Prevention on Wednesday said more people are dying of
antibiotic-resistant infections, despite hospitals' efforts to prevent acquired
conditions.
More than 2.8
million infections occur each year, causing more than 35,000 deaths, according
to the latest CDC estimates. Although that's more infections than the agency
estimated for 2013, when there were 2.6 million annual infections, the
mortality rate has dropped from 44,000 deaths per year. That's an 18% drop
since the CDC revised its 2013 numbers.
CDC Director Dr.
Robert Redfield said the revised numbers stemmed from new data sources that
were previously unavailable. He urged clinicians to continue vigilant infection
control to ensure those numbers continue to decrease.
"Despite
significant progress this threat remains our enemy," Redfield said.
The CDC added two
germs to its "urgent threat" infection list since the 2013 report: a
drug-resistant form of candida auris and carbapenem-resistant acinetobacter.
The former is a fungal infection that kills one in three patients it affects.
The infection was elevated to "urgent" status due to its rapid global
spread over the past year, with more than 836 cases confirmed
in the U.S. as of Oct. 29.
The latter
infection causes pneumonia and wound, bloodstream and urinary tract infections
and was responsible for 8,500 hospitalizations and 700 deaths in 2017 with
nearly all cases acquired in healthcare settings.
"With
emerging threats like this, the modern medicine available to us today can very
well be gone tomorrow if we don't slow the development of antibiotic
resistance," Redfield said.
The decrease in
deaths and rise in total infections may reflect a shift in where care is given.
Outpatient sites generally see less severe infections than hospitals.
"We probably
have made some significant strides in the hospital setting but the question me
is what is going on in the community," said Dr. Emily Sydnor Spivak,
associate professor of medicine at University of Utah Health's Division of
Infectious Diseases. "Do we need to transition and do a lot more in the
outpatient setting and agriculture sector."
Antibiotic-resistant
infections that are most often acquired within healthcare settings accounted
for 85% of all deaths calculated in the report. That stems partly from decades
of antibiotic overprescribing. The more an antibiotic is used, the less
effective it becomes as resistance increases.
Antibiotic
stewardship efforts have focused on hospitals. In 2017, the Joint Commission began
requiring acute-care and critical access hospitals as well as nursing homes to
have an antibiotic stewardship program as a condition of maintaining their
accreditation.
By 2018, more
than 76% of the country's nearly 5,000
acute-care hospitals reported having an antibiotic stewardship
program.
In September, the
CMS finalized a rule
requiring all hospitals that participate in Medicare and Medicaid to have an
antibiotic stewardship program.
That work has led
to a more than 27% decrease in the number of antimicrobial-resistant infections
acquired in hospitals from 2012 to 2017, according to the CDC report. Deaths
from antibiotic-resistant infections over that period fell by 28% in hospitals.
The report's
findings confirm the need to focus effort on improving antibiotic use within
community-based settings, according to Dr. David Hyun, senior officer at the
Pew Charitable Trusts' Antibiotic Resistance Project.
"It has been
encouraging to see those efforts are making a positive impact, but it also
underscores we have a long way to go," he said. "Places like
outpatient centers need the same level of attention that hospitals have
received in recent years."
Hyun and others
have pointed out there is a large gap in antibiotic oversight at outpatient
facililities including retail health clinics and urgent care centers.
A 2018 JAMA Internal Medicine study
found 40% of all outpatient antibiotic prescriptions were written at an urgent
care center or retail health clinic, but 46% of those patients didn't require
those drugs.
"We have
more obvious federal policy levers for inpatient settings," said Kathy
Talkington, project director for Pew's Antibiotic Resistance Project. "In
the outpatient setting it's less clear what those policy levers are — it's
clearly an area we need to keep focusing on to figure out what incentives need
to be in place to drive good stewardship."
No comments:
Post a Comment